florbetapir F 18 PET scan

DRUG2 trials

Sponsors

Avid Radiopharmaceuticals, Eli Lilly and Company

Conditions

Alzheimer DiseaseCognition DisordersMild Cognitive Impairment

Unknown Phase

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

CompletedNCT02918539

Avid RadiopharmaceuticalsAlzheimer Disease, Cognition Disorders

Start: 2016-10-31End: 2017-10-18Updated: 2018-10-24

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Active, not recruitingNCT02951598

Eli Lilly and CompanyAlzheimer Disease, Mild Cognitive Impairment

Start: 2016-10-29End: 2026-04-28Target: 1400Updated: 2025-10-24

Related Papers

Healthcare costs incurred by patients before entering GERAS‐US, a prospective, observational study of early Alzheimer’s disease: Impact of disease severity and amyloid status

Alzheimer s & Dementia2021-12-01

Observation of Patient and Caregiver Burden Associated with Early Alzheimer’s Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1

Journal of Alzheimer s Disease2019-09-2417 citations